Arjo AB (publ)

BATS-CHIXE:ARJOBS Stock Report

Market Cap: SEK 10.0b

Arjo Valuation

Is ARJOBS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ARJOBS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
SEK 90.94
Fair Value
60.0% undervalued intrinsic discount
5
Number of Analysts

Below Fair Value: ARJOBS (SEK36.4) is trading below our estimate of fair value (SEK90.94)

Significantly Below Fair Value: ARJOBS is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ARJOBS?

Key metric: As ARJOBS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ARJOBS. This is calculated by dividing ARJOBS's market cap by their current earnings.
What is ARJOBS's PE Ratio?
PE Ratio19.9x
EarningsSEK 505.00m
Market CapSEK 10.04b

Price to Earnings Ratio vs Peers

How does ARJOBS's PE Ratio compare to its peers?

The above table shows the PE ratio for ARJOBS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.5x
NIOX NIOX Group
21.1x15.8%UK£230.0m
EKF EKF Diagnostics Holdings
25.2xn/aUK£120.2m
SN. Smith & Nephew
34.5x22.6%UK£8.6b
AMS Advanced Medical Solutions Group
37.3x20.5%UK£415.2m
ARJOBS Arjo
19.9x23.3%SEK 10.0b

Price-To-Earnings vs Peers: ARJOBS is good value based on its Price-To-Earnings Ratio (19.9x) compared to the peer average (29.9x).

Price to Earnings Ratio vs Industry

How does ARJOBS's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies9PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ARJOBS is good value based on its Price-To-Earnings Ratio (19.9x) compared to the European Medical Equipment industry average (31.1x).

Price to Earnings Ratio vs Fair Ratio

What is ARJOBS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ARJOBS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ARJOBS's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ARJOBS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 36.40
SEK 41.00
+12.6%
7.4%SEK 45.00SEK 37.00n/a5
Jan ’26SEK 35.33
SEK 41.00
+16.0%
7.4%SEK 45.00SEK 37.00n/a5
Dec ’25n/a
SEK 41.60
0%
5.8%SEK 45.00SEK 39.00n/a5
Nov ’25n/a
SEK 44.00
0%
15.3%SEK 57.00SEK 39.00n/a5
Oct ’25n/a
SEK 52.60
0%
9.0%SEK 58.00SEK 45.00n/a5
Sep ’25n/a
SEK 51.80
0%
11.3%SEK 58.00SEK 42.00n/a5
Aug ’25n/a
SEK 51.80
0%
11.3%SEK 58.00SEK 42.00n/a5
Jul ’25n/a
SEK 51.25
0%
18.4%SEK 58.00SEK 35.00n/a4
Jun ’25SEK 45.83
SEK 51.25
+11.8%
18.4%SEK 58.00SEK 35.00n/a4
May ’25n/a
SEK 51.25
0%
18.4%SEK 58.00SEK 35.00n/a4
Apr ’25n/a
SEK 51.60
0%
17.1%SEK 60.00SEK 35.00n/a5
Mar ’25n/a
SEK 51.60
0%
17.1%SEK 60.00SEK 35.00n/a5
Feb ’25n/a
SEK 50.60
0%
16.6%SEK 60.00SEK 35.00n/a5
Jan ’25n/a
SEK 44.25
0%
22.5%SEK 55.00SEK 30.00SEK 35.334
Dec ’24n/a
SEK 44.25
0%
22.5%SEK 55.00SEK 30.00n/a4
Nov ’24n/a
SEK 50.00
0%
14.1%SEK 55.00SEK 40.00n/a3
Oct ’24n/a
SEK 50.67
0%
12.1%SEK 55.00SEK 42.00n/a3
Sep ’24n/a
SEK 50.33
0%
13.1%SEK 55.00SEK 41.00n/a3
Aug ’24SEK 44.68
SEK 50.33
+12.7%
13.1%SEK 55.00SEK 41.00n/a3
Jul ’24SEK 38.49
SEK 50.67
+31.6%
12.1%SEK 55.00SEK 42.00n/a3
Jun ’24n/a
SEK 52.33
0%
14.5%SEK 60.00SEK 42.00SEK 45.833
May ’24n/a
SEK 46.67
0%
20.5%SEK 60.00SEK 38.00n/a3
Apr ’24n/a
SEK 44.33
0%
25.1%SEK 60.00SEK 35.00n/a3
Mar ’24SEK 40.44
SEK 44.33
+9.6%
25.1%SEK 60.00SEK 35.00n/a3
Feb ’24SEK 40.10
SEK 46.67
+16.4%
22.0%SEK 60.00SEK 35.00n/a3
Jan ’24SEK 38.54
SEK 53.25
+38.2%
15.6%SEK 63.00SEK 45.00n/a4
Analyst Price Target
Consensus Narrative from 5 Analysts
SEK 40.49
Fair Value
10.1% undervalued intrinsic discount
5
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 18:11
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arjo AB (publ) is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sten GustafssonABG Sundal Collier
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Karl NorénDanske Bank